NIF Ventures (a member of Daiwa Securities Group) and SMBC Capital (a member of Sumitomo Mitsui Financial Group) merged on October 1, 2005 to form NIF SMBC Ventures. Both were well-established brands within the venture capital industry, being involved in listing various companies. After the merger, having grown out of a securities firm and a bank, NIF SMBC Ventures is a venture capital firm that maximizes use of its broad business network, longstanding experience and know-how while implementing investment operations. Disclaimer: the development of new drug technologies is difficult, erratic and unpredictable. Endotis Pharma's forecasts and future economic performance depend on research that has yet to be performed and on a number of other factors. The company's future economic performance may differ significantly from that currently forecast.
View Top Employees from NIF Ventures| Website | http://www.nif.co.jp |
| Revenue | $9 million |
| Employees | View employees |
| Phone | +81 3-5695-8250 |
| Industry | Finance General, Finance |
| Competitors | ATA Ventures, Globespan Capital Partners, Sequel Venture Partners, Silverton Partners, Split Rock Partners |
| SIC | SIC Code 67 Companies, SIC Code 679 Companies |
| NAICS | NAICS Code 52 Companies, NAICS Code 5239 Companies, NAICS Code 523 Companies |
Looking for a particular NIF Ventures employee's phone or email?
NIF Ventures Questions
The NIF Ventures annual revenue was $9 million in 2024.
The NAICS codes for NIF Ventures are [52, 5239, 523].
The SIC codes for NIF Ventures are [67, 679].
Related Companies
